FDA Approval History
This list consists of medications tracked by Drugs.com through the application and approval process at the U.S. Food and Drug Administration (FDA). Where possible, we have assembled information in chronological order to show the history of a medication. May only show partial information and does not include non-US drug approvals. For information about non-US medications, please visit the international drugs section.
Latest drug approvals
- Pivya (pivmecillinam) - April 24, 2024
- Ojemda (tovorafenib) - April 23, 2024
- Anktiva (nogapendekin alfa inbakicept-pmln) - April 22, 2024
- Lumisight (pegulicianine) - April 17, 2024
- Selarsdi (ustekinumab-aekn) - April 16, 2024
- Zevtera (ceftobiprole medocaril) - April 03, 2024
- Risvan (risperidone) - March 29, 2024
- Voydeya (danicopan) - March 29, 2024
- Vafseo (vadadustat) - March 27, 2024
- Winrevair (sotatercept) - March 26, 2024
- Opsynvi (macitentan and tadalafil) - March 22, 2024
- Pemgarda (pemivibart) - March 22, 2024
- Duvyzat (givinostat) - March 21, 2024
- Tryvio (aprocitentan) - March 19, 2024
- Lenmeldy (atidarsagene autotemcel) - March 18, 2024
- Rezdiffra (resmetirom) - March 14, 2024
- Tevimbra (tislelizumab-jsgr) - March 13, 2024
- Jubbonti (denosumab-bbdz) - March 05, 2024
- Tyenne (tocilizumab-aazg) - March 05, 2024
- Wyost (denosumab-bbdz) - March 05, 2024